ClinicalTrials.gov
ClinicalTrials.gov Menu

ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01218048
Recruitment Status : Active, not recruiting
First Posted : October 8, 2010
Last Update Posted : September 7, 2017
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Robert Ferris, University of Pittsburgh

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2017
  Estimated Study Completion Date : October 2018

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 February 8, 2018
March 12, 2018
2 April 5, 2018
May 4, 2018
3 May 16, 2018
June 11, 2018